Stocks and shapes

3rd Apr 2020

Seb Jory discusses the significant challenges and exciting opportunities presented in the markets today

We hope you are all keeping well and stay well. Welcome to a new mid-month missive from Tellworth where we plan to look at broader themes away from the very specific trials and tribulations of our funds that we cover in monthly letters. This idea has long been in our minds and when better to unleash on you than now when every question has a dozen conflicting answers?

Current state of play – Bunkers have boomed

Forget index records – within markets, the gap between winners and losers has been nothing short of seismic. We have had the largest stock dispersion on record – at a 40% standard deviation of sector returns reported by S&P Global – and all in the space of about a month. UK Travel, Pubs and Events businesses have at least halved in value. But many Food Delivery, Supermarkets and Motor Insurance stocks – we will call them the Bunkers – are well above their pre-COVID levels.

This is, of course, a function of equally unprecedented changes in consumer demand. As we look across our UK ThermoStat indicators, we see searches for holidays down 70%, visits to retail websites down 40%, interest in bankruptcy and insolvency solutions up 20% and new residential listings down 80%. This is not a functioning economy, or one in which consumer focused indicators of any kind really serve any purpose. Simply: everything has stopped.

Aside from whether your customers have totally disappeared, another important market dynamic has been the inevitable ‘tree shake’ that comes with any systemic risk event. Companies that are less insulated – low margins and high debt – have generally fared much worse than those with stronger models and balance sheets, regardless of sector. The return difference is a chunky 15% – the gap between the green (50 high margin stocks) and red (50 low margin) dots below – again, most of it within the 4 weeks after Feb 20th. This is the time when under-appreciated quality comes to the fore.

Fig 1: Winners and Losers Compendium

Sub-sector relative Return since 20/02/2020, worst to best

Source: Bloomberg, Tellworth Investments. Low Margins = <10% EBIT margin, High Margins >25%. Size of circle = number of companies

Shape of the eventual recovery – Is it the wrong question?

V, W or U? This is the question most asked by the sell-side strategists we read. Most are in camp V. The logic goes that if we see some stabilisation of new case and death numbers – and increasingly this looks imminent – then the market will look through the short-term economic pain much like a natural disaster, so buy the stocks on the left of the above chart and sell the right. The caveat (and strategists love a caveat – see any of my old sell-side notes) is that if there is re-infection (W) or extended lockdown (U) then you should position the reverse. In other words, the economic patient and the medical patient are one and the same.

This may well prove to be right but it requires a big leap of faith. The examples of brushes with 15% unemployment are relatively few. Examples of these followed by quick recoveries are, we think, zero. True, we have seen some very impressive policy, both in scale and timeliness. This gives us pause for thought. If it can smooth reaction functions in both firms and individuals, then we stand a good chance of some proper catch-up spending in the autumn.

But what we think is being a little underestimated is frictions. Aside from the economics textbook ‘classics’ – consumption’s non-linear relationship to time unemployed – there are numerous other examples littered across the company reports we read (“capex delayed until FY21”, “12 month hiring freeze”, “actively reducing inventory” etc.). Uncertainty and economic activity are very closely related – believing in a V-shape requires at least an A-shape in uncertainty – this seems a big ask whilst also telling companies you don’t even know when the end of the beginning (i.e. universal lockdown) will be.

Perhaps a bigger albeit more abstract issue is that this is in a financial system that is really not set up for this kind of shock. Gross fixed leverage, driven principally by non-Bank lending in the last 10 years, is at record highs relative to the economy. Deleveraging for companies after this event will be high on the list (not a good thing at GDP level). All said, we find it hard to imagine that the speed of the rebound in the corporate mind-set, and the time spent at zero revenues for many companies is critical here, will be particularly quick.

Opportunities in the As and the Bs… but be careful of the Ds

Fortunately, we do not have to make bold economic predictions or make big bets on bond yields. Indeed, our framework at Tellworth is not one typically based on gut-feel judgements such as those in the prior paragraphs. Principally we base it on the most ‘live’ data we can find on the health of the economy – the indicators within our UK ThermoStat model. Regardless of any former biases, if we see mortgage searches recover strongly, to give one early-cycle example, it would encourage us to do further work on related end-markets – perhaps housebuilding. It is when sizing up the rebound, then, that we hope and expect our indicators to deliver their most valuable insights.

The approach at the moment, however, is more nuanced. We require some judgement on the economy due to the lack of immediately useable data, but it is quite marginal. After the mega-dispersion we have seen, there are enough opportunities and inconsistencies, we think, in the UK equity market at the moment such that we actually want to minimise the exposure to ‘factors’ – i.e. not have so many near- term winners or losers that swings in sentiment drive our performance.
The biggest opportunity that we can see, and of course we will be oversimplifying, is between groups B and C in the below figure – all similarly big underperformers. This chimes with our earlier thoughts on economics vs. immediate epidemic impact. Indeed, traditional cyclicals in group D, like Cap Goods and Media have been relative winners, despite likely challenging end markets for well over a year.

Fig 2: Team Sheets – Sub-Sector groupings by exposure, April ’20

Our key judgement then, when shaping the UK Select portfolio, is that we want to focus our recovery stocks from Group B, where the longer-lasting economic damage will have less of an impact but pricing is keen. Of course, we need plenty from the bunkers too, the A-team, to help ensure a reasonable portfolio outcome if we see further shutdowns. The key consideration here is whether their valuation has out-run their defensiveness – this is a micro call. We want a good proportion of our short positions to be from the GDP sensitives (the Ds), especially those ona higher valuation – perhaps still on an unwarranted premium for defensiveness. Finally, the Cs stand for case-by-case. The double impact of COVID restriction and cyclicality make earnings near impossible to model. If we had a rule here it would be to buy the ‘best stocks in the worst neighbourhoods’ – we want strong balance sheets and a resilient model, but this typically comes at a hefty premium.

To zoom out a bit, the most important thing for us as stock pickers remains focussing on owning shares in companies that will be innovators and market leaders over the next several years – our tried and tested ‘P3M’ approach. So whilst the core of the portfolio will remain largely unchanged, retaining the flexibility to be opportunistic is vital in markets like the ones we study today. The record breaking dispersion has brought some of the widest set of opportunities you can see in investing – our job is to use the tools we have developed in the quieter times to take advantage of this.

Seb Jory co-manages our TM Tellworth UK Select fund, a large cap UK absolute return UCITS strategy that has delivered +6.33% YTD (vs the FTSE All Share -23.2%) and +7.27% since Tellworth took on the management of this fund from Sanditon AM on 12/12/2019 (returns quoted are net of fees on the F share class as of 19/04/2020. Source: FE Analytics, Bloomberg).


This document may not be used for purposes other than those for which it is intended, nor may it be reproduced, distributed or transmitted in whole or in part to third parties without the prior written consent of Tellworth Investments LLP. This document has been produced for information purposes only.

BennBridge and Tellworth decline all responsibility in the event of a decision whether or not made on the basis of the information contained in this document or in the event of any use whatsoever of said information which may be made by a third party.

Tellworth is a UK and European equity investment management boutique which launched in partnership with BennBridge Ltd.

BennBridge is authorised and regulated by the UK Financial Conduct Authority (FRN: 769109) with registered address: C/O Windsor House 5 Station Court, Station Road, Great Shelford, Cambridge, England, CB22 5NE.

Tellworth is an Appointed Representative (FCA FRN: 787570) of BennBridge pursuant to the terms of an appointed representative services agreement.

More posts

Terms & Conditions of Use

To access all areas of this website please read the Terms & Conditions set out below and then click ‘Agree’.

This website is suitable for investment professionals only and not for retail investors.

1. Important Information

Tellworth Investments LLP (“Tellworth”) is a limited liability company registered in England with registered number OC417414. The registered office is Windsor House, Station Court, Station Road, Great Shelford, Cambridge CB22 5NE. Tellworth is authorised and regulated by the Financial Conduct Authority (FRN: 952383). Tellworth is the UK regulated entity and the appointed investment manager to the Funds referred to throughout this website.

Any projections, market outlooks or estimates contained in this website constitute forward looking statements, and are based on certain assumptions and subject to certain known and unknown risks. Accordingly, such forward looking statements should not be relied upon as being indicative of future performance or events.

Past performance is not indicative of future results. The value of investments and the income from them may go down as well as up and investors may not get back the amounts originally invested.

In the United Kingdom this website is only available to professional investors meeting the criteria for professional clients set out in COBS 3.5 of the Conduct of Business Sourcebook in the Financial Conduct Authority’s Handbook of rules and guidance, including ‘investment professionals’ within the meaning of Article 19(5) of the Financial Services and Markets Act (Financial Promotion) Order 2005 or Article 14(5) of the Investment Services and Markets Act 2000 (Promotion of Collective Investment Schemes) (Exemptions) Order 2001.

This website is being provided by Tellworth for informational purposes only and should not be construed as investment advice. It is not a recommendation of, or an offer to sell or solicitation of an offer to buy, any particular security, strategy or investment product.

2. Risk Factors

The counterparty to a derivative or other contractual agreement or synthetic financial product could become unable to honour its commitments to the fund, potentially creating a partial or total loss for the fund. The fund can be exposed to different currencies. Changes in foreign exchange rates could create losses. A derivative may not perform as expected, and may create losses greater than the cost of the derivative. If a fund uses derivatives for leverage, it makes it more sensitive to certain market or interest rate movements and may cause above-average volatility and risk of loss.

Equity prices fluctuate daily, based on many factors including general, economic, industry or company news. In difficult market conditions, the fund may not be able to sell a security for full value or at all. This could affect performance and could cause the fund to defer or suspend redemptions of its shares. The fund may take positions that seek to profit if the price of a security falls. A large rise in price of the security may cause large losses. Failures at service providers could lead to disruptions of fund operations or losses.

3. Not for US Persons

The provision of the information in this web site does not constitute an offer of securities to any person in the United States or to any U.S. Person as defined under the Securities Act of 1933, as amended. The information contained in this site about Tellworth is not directed to any person in the United States. Funds referred to herein are neither registered under the Securities Act 1933 of the USA, nor are they registered under the Investment Company Act of 1940. Consequently, they cannot be offered for sale or be sold in the USA, its territories, possessions or protectorates under its jurisdiction, nor to nationals, citizens or residents in any of those areas.

No investments or services mentioned on this website are directed at US Persons who are not Professional Clients or Eligible Counterparties as defined by the UK Financial Conduct Authority (FCA) Handbook or Qualified Purchasers as defined under the Investment Company Act of 1940. The information contained herein does not constitute a distribution, an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction in which such distribution or offer is not authorised.

4. Your use of our site

When using our site, you must comply with all applicable local, national and international laws and regulations, including those related to data privacy, international communications and exportation of technical or personal data. It may be illegal to download the information contained on our site in certain countries and we and our affiliated companies disclaim all responsibility if you download any information from our site in breach of any law or regulation of the country in which you reside.

5. Liability for use of our site

Access to our site is permitted on a temporary basis and we reserve the right to withdraw or amend the service we provide on our site without notice. We do not accept any liability if for any reason our site is unavailable at any time or for any period.

The information and any opinions contained on the site are subject to change, are for background purposes only and are not to be relied upon as advice or interpreted as a recommendation. The information and opinions contained in our site have been compiled, or arrived at, by us from sources believed by us to be reliable as at the date of publication. However, we, our affiliated companies and other third parties connected to us do not accept any responsibility for any reliance which is placed by any visitor to our site, or by anyone who may be informed of any of its contents, on any information or opinions which are expressed herein and, to the extent permitted by law, expressly exclude all conditions, warranties, representations, undertakings and other terms which might otherwise be implied by statute, common law or in equity.

The internet is not a completely reliable transmission medium and neither we nor any of our affiliated companies accept any liability for any data transmission errors such as data loss or damage or alteration of any kind or for the security or confidentiality of information transmitted across the internet to or from us or any of our affiliated companies. Any such transmission of information is entirely at your own risk. This does not exclude or restrict any duty or liability that we have to our customers under the regulatory system in the United Kingdom.

Should you leave our site via a link contained within our site and view content that is not provided by us, you do so at your own risk. We provide links only as a convenience and without liability. In particular, and without limitation, you understand and agree that the ability to link to another web site and the fact that a link exists does not mean that we endorse or guarantee such site, the site sponsor or the site contents. The content which you access via such links will not have been developed, checked for accuracy, or otherwise reviewed by us. We make no guarantees or representations as to, and shall have no liability for, any electronic content delivered by any third party, including, without limitation, the accuracy, subject matter, quality, sequence or timeliness of any electronic content. Your reliance on any information contained on any site reached through a link shall be your own responsibility. When you leave our site, unless otherwise indicated, you will be subject to the terms of use and privacy policies of the new web site which you are visiting. If you reached our site via a link, please be advised that the ability to link to our site and the fact that a link exists does not mean that we necessarily endorse, support, sanction, encourage, verify, or agree with the comments, opinions, or statements posted on the web site from which you linked to our site (the “Linking Site”). We are not responsible for any damages or losses arising from any delays, defects or omissions that may exist in the services, information or other content provided in the Linking Site. We make no guarantee or representation as to, and shall have no liability for, any content on any Linking Site, including, without limitation, the accuracy, subject matter, quality, sequence or timeliness of any such content.

6. Indemnity

You agree to indemnify, defend, and hold harmless us, our affiliates and our officers, partners, employees, and agents from and against any and all claims, liabilities, damages, losses, or expenses, including legal fees and costs, arising out of or in any way connected with your breach of the terms of use and/or access to or use of this site.

7. Intellectual property rights

We are the owner or the licensee of all intellectual property rights in our site, and in the materials published on it. Those works are protected by laws and treaties around the world. All such rights are reserved. You may use the materials on our site and download and reproduce them in hard copy for your own reference only. Such materials may not otherwise be reproduced, distributed, stored in a data retrieval system or transmitted, in any form or by any means (electronic, mechanical, photocopying, recording or otherwise) without our prior written consent. Nothing on our site should be construed as granting any licence or right in relation to any of our trademarks or those of our affiliated companies or any third party.

8. Material Interests

We and our partners, officers and/or employees may have holdings in the investment funds referred to on this site and may otherwise be interested in transactions that you effect in those funds.

9. Your personal data

We may collect and process the following data about you in accordance with the terms of use:

information that you provide by filling in forms on our site, including information provided at the time of registering to use our site, subscribing to our service, posting material or requesting further services;

if you contact us, we may keep a record of that correspondence;

details of your visits to our site and the materials and information that you access, for the following purposes:

to provide you with information, products or services that you request from us or which we consider may interest you, where you have consented to be contacted for such purposes;

to allow you to participate in interactive features of our service, when you choose to do so;

to determine your suitability to be granted access to our site.

10. Disclosure of your personal data

Any personal data relating to you will be collected, used and recorded by us in accordance with the Data Protection Act of 1998 and will comply with relevant legislative changes, the Terms of Use and our Privacy Policy below. You must read our Privacy Policy as it forms part of the Terms of Use. By using this site, you consent to processing of your personal data in accordance with our terms of use and you warrant that all data provided by you is accurate.

11. Our website uses Cookies

Cookies are small text files which are placed on the computer of a website user to provide the website operator with information about use of the site. We use Google Analytics cookies to collect information, in an anonymous form, about how visitors use our site and to prepare reports for statistical analysis. The information collected includes the number of visitors to the site, where visitors have come to the site from and the pages that they have visited. We use the information to help us improve the site and users’ experience of it.

By accepting these website terms of use you consent to the use of these cookies for these purposes.

12. Law and variation

These terms of use and any non-contractual obligations arising from or connected with them shall be governed by and shall be construed in accordance with English law. English courts will have exclusive jurisdiction over any dispute arising from, or related to, use of our site (whether arising out of or in connection with contractual or non-contractual obligations) (“proceedings”) and it is a condition of using our site that you waive any objection to proceedings in such courts on the grounds of venue or that proceedings have been brought in an inconvenient forum, although we retain the right to bring proceedings against you for breach of these terms of use in your country of residence or any other relevant country.

We may revise these terms of use at any time by amending this page. You are expected to check this page from time to time to take notice of any changes we made, as by using our site you acknowledge that you have accepted any such amendments.